Wegovy®
A weekly GLP-1 treatment proven to reduce hunger and support meaningful, long-term fat loss.
- ~16.9% average body weight loss
- Boosts metabolic & cardiovascular health
- Proven, long-established safety profile
- Weekly injection, easy to use

Mounjaro (tirzepatide) is a prescription medicine licensed in the UK for type 2 diabetes that has also demonstrated substantial weight reduction in clinical trials. Many patients wonder whether they can safely consume alcohol whilst taking this medication. Whilst there is no absolute contraindication to drinking alcohol on Mounjaro, the combination raises important considerations regarding blood glucose control, gastrointestinal side effects, and weight loss outcomes. Understanding how alcohol interacts with tirzepatide can help you make informed decisions about drinking during treatment. This article examines the evidence and provides practical guidance on Mounjaro, weight loss, and alcohol consumption.
Summary: You can drink alcohol whilst taking Mounjaro, but it may worsen gastrointestinal side effects, increase hypoglycaemia risk, and undermine weight loss results through added calories.
Mounjaro (tirzepatide) is a prescription medicine licensed in the UK for the treatment of type 2 diabetes mellitus. It is administered as a once-weekly subcutaneous injection and belongs to a novel class of medications known as dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonists.
The mechanism of action of tirzepatide involves mimicking two naturally occurring incretin hormones that play crucial roles in glucose regulation and appetite control. By activating both GIP and GLP-1 receptors, Mounjaro enhances insulin secretion in a glucose-dependent manner, suppresses glucagon release when blood glucose is elevated, and slows gastric emptying. These combined effects lead to improved glycaemic control in people with diabetes.
Whilst licensed for diabetes, tirzepatide also affects appetite and satiety. It acts on areas of the brain involved in appetite regulation, leading to reduced hunger and increased feelings of fullness after eating. Clinical trials such as the SURMOUNT studies have demonstrated substantial weight reduction in participants using tirzepatide, with average weight loss of approximately 15-20% of initial body weight over 72 weeks when combined with lifestyle modifications, though results vary between individuals.
In the UK, Mounjaro is available through the NHS for eligible patients with type 2 diabetes who meet specific criteria outlined in NICE guidance, as well as through private prescription. Use for weight management without diabetes is currently off-label and not routinely commissioned on the NHS. Treatment should always be initiated and supervised by a healthcare professional experienced in the management of diabetes, with a typical starting dose of 2.5mg weekly, gradually titrated upwards as tolerated.
There is no absolute contraindication to consuming alcohol whilst taking Mounjaro, and the medication's Summary of Product Characteristics does not list alcohol as a specific interaction requiring complete avoidance. However, this does not mean that drinking alcohol whilst on tirzepatide is without considerations or potential risks that patients should understand.
The primary concern relates to the fact that both Mounjaro and alcohol can independently affect blood glucose levels and gastrointestinal function. Alcohol consumption, particularly in larger quantities or without food, can cause hypoglycaemia (low blood sugar), especially in people taking diabetes medications. Whilst Mounjaro's glucose-lowering effect is glucose-dependent and carries a lower intrinsic risk of hypoglycaemia compared to some other diabetes treatments, the combination with alcohol may still increase this risk, particularly if you are also taking other glucose-lowering medications such as insulin or sulphonylureas.
Additionally, alcohol is a gastrointestinal irritant and can cause nausea, vomiting, and stomach discomfort—side effects that are already commonly reported with Mounjaro, especially during the initial weeks of treatment or following dose increases. Combining alcohol with tirzepatide may therefore exacerbate these gastrointestinal symptoms and make them more difficult to tolerate.
If you have diabetes and choose to drink alcohol while taking Mounjaro, practical safety measures include: eating carbohydrate-containing food when drinking, checking your blood glucose before bed (as alcohol can cause delayed hypoglycaemia), carrying fast-acting glucose and medical ID, and discussing potential dose adjustments of insulin or sulphonylureas with your prescriber.
Patients should discuss alcohol consumption with their prescribing clinician, particularly if they have diabetes, liver disease, a history of pancreatitis, or other relevant medical conditions. Your healthcare provider can offer personalised advice based on your individual health status, concurrent medications, and treatment goals.

Alcohol consumption can significantly undermine weight loss efforts for several physiological and behavioural reasons, which is particularly relevant for individuals using Mounjaro as part of a weight management programme. Understanding these effects can help patients make informed decisions about alcohol intake during treatment.
Firstly, alcohol is calorically dense, providing approximately 7 kilocalories per gram—nearly as much as fat (9 kcal/g) and significantly more than carbohydrates or protein (4 kcal/g each). These are often referred to as "empty calories" because alcoholic beverages typically provide little to no nutritional value. A standard glass of wine (175ml) contains around 120–150 calories and approximately 2 units of alcohol, whilst a pint of beer may contain 180–250 calories and 2-3 units. Regular alcohol consumption can therefore substantially increase total daily caloric intake, counteracting the caloric deficit necessary for weight loss.
Secondly, alcohol metabolism takes priority in the liver, which can temporarily reduce the body's ability to metabolise fat. This metabolic shift may affect fat oxidation and promote fat storage, particularly in the abdominal region. Additionally, alcohol can stimulate appetite and reduce inhibitions, often leading to increased food intake and poor dietary choices—a phenomenon commonly experienced after drinking.
High-sugar mixers in alcoholic drinks (such as cola, lemonade, or fruit juices) add significant additional calories. A single gin and tonic can contain 170-200 calories, while cocktails may exceed 300 calories per serving.
Alcohol may also affect adherence to the lifestyle modifications that are essential components of any weight management programme. These include regular physical activity, consistent meal planning, and adequate sleep—all of which can be disrupted by alcohol consumption. Furthermore, hangovers and the general malaise associated with drinking can reduce motivation for exercise and healthy eating.
For optimal weight loss results with Mounjaro, patients are generally advised to minimise alcohol intake or avoid it altogether. If you choose to drink, doing so occasionally and in moderation (within UK Chief Medical Officers' guidelines of no more than 14 units per week), whilst accounting for the additional calories in your overall dietary plan, is the most sensible approach.
Combining Mounjaro with alcohol may increase the risk or severity of certain adverse effects, although there is no official direct pharmacological interaction documented between tirzepatide and ethanol. Understanding these potential risks is important for patient safety and treatment tolerability.
Gastrointestinal side effects are the most commonly reported adverse reactions with Mounjaro, affecting a significant proportion of users, particularly during treatment initiation and dose escalation. These include:
Nausea and vomiting
Diarrhoea
Constipation
Abdominal pain and discomfort
Reduced appetite
Alcohol is a known gastric irritant and can independently cause similar gastrointestinal symptoms. When combined with Mounjaro, there is a reasonable likelihood that these effects may be additive, leading to more pronounced or prolonged discomfort. Severe vomiting and diarrhoea can also lead to dehydration and potentially acute kidney injury, which may be exacerbated by alcohol's diuretic effect.
Hypoglycaemia risk, whilst relatively low with Mounjaro monotherapy due to its glucose-dependent mechanism, may be increased when alcohol is consumed, particularly if meals are skipped or delayed. Symptoms of low blood sugar include tremor, sweating, confusion, palpitations, and in severe cases, loss of consciousness. This risk is heightened in patients taking additional glucose-lowering medications.
Pancreatitis is a rare but serious potential side effect of GLP-1 receptor agonists, including Mounjaro. Alcohol consumption, especially heavy or binge drinking, is itself a well-established risk factor for acute pancreatitis. Patients with a history of pancreatitis should avoid alcohol entirely and use Mounjaro only under close medical supervision.
Gallbladder problems including gallstones can occur with GLP-1/GIP therapies like Mounjaro, particularly during substantial weight loss. Symptoms include sudden severe pain in the upper right abdomen, fever, and jaundice (yellowing of skin/eyes). Alcohol consumption may exacerbate these risks in susceptible individuals.
Patients with pre-existing liver disease should exercise particular caution with alcohol while taking Mounjaro.
If you experience severe abdominal pain, persistent vomiting, signs of hypoglycaemia, inability to keep fluids down for more than 8 hours, or any other concerning symptoms after consuming alcohol whilst taking Mounjaro, call 999 or go to A&E immediately. For non-urgent advice, contact your GP or call NHS 111.
Suspected adverse reactions to Mounjaro can be reported via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk or through the Yellow Card app.
If you choose to consume alcohol whilst taking Mounjaro, following evidence-based guidelines can help minimise risks and support your weight loss goals. The UK Chief Medical Officers recommend that to keep health risks from alcohol low, it is safest not to drink more than 14 units per week on a regular basis, spread over three or more days, with several alcohol-free days each week. One unit equals 10ml or 8g of pure alcohol, which is roughly equivalent to half a pint of regular-strength beer, a small glass (125ml) of wine, or a single measure of spirits.
Practical recommendations include:
Start slowly: If you are new to Mounjaro or have recently increased your dose, it is advisable to avoid alcohol until you know how your body responds to the medication, particularly regarding gastrointestinal side effects.
Drink with food: Never consume alcohol on an empty stomach, especially when taking Mounjaro. Eating a balanced meal containing carbohydrates can help slow alcohol absorption and reduce the risk of hypoglycaemia and gastrointestinal upset.
Stay hydrated: Drink water before, during, and after alcohol consumption to counteract dehydration, which can worsen side effects such as nausea and headache.
Monitor blood glucose: If you have diabetes, check your blood glucose levels more frequently when drinking alcohol, particularly before bed, and be aware of delayed hypoglycaemia, which can occur several hours after drinking. Consider having a carbohydrate-containing snack before sleeping.
Choose lower-calorie options: If weight loss is your primary goal, opt for lower-calorie alcoholic beverages such as spirits with sugar-free mixers (approximately 60-80 calories per single measure), dry wine (approximately 120-130 calories per 175ml glass), or light beer, and be mindful of portion sizes.
Avoid binge drinking: Heavy episodic drinking significantly increases risks of hypoglycaemia, pancreatitis, and other serious complications.
Carry precautions: If you have diabetes, always carry fast-acting glucose and medical identification, especially when drinking alcohol.
Discuss your individual circumstances with your healthcare provider, particularly if you have diabetes, liver disease, a history of pancreatitis, or are taking other medications. Your GP or specialist can provide personalised advice and may recommend complete alcohol avoidance depending on your medical history and treatment response. Remember that successful weight management with Mounjaro depends not only on the medication itself but also on sustainable lifestyle changes, of which moderating alcohol intake is an important component.
Yes, there is no absolute contraindication to drinking alcohol whilst taking Mounjaro, but it may worsen gastrointestinal side effects, increase hypoglycaemia risk, and add significant calories that undermine weight loss. Discuss your individual circumstances with your healthcare provider for personalised advice.
Alcohol provides approximately 7 kilocalories per gram and offers little nutritional value, significantly increasing daily caloric intake. It can also stimulate appetite, reduce fat metabolism, and disrupt lifestyle modifications essential for weight loss, thereby counteracting Mounjaro's effectiveness.
Combining Mounjaro and alcohol may increase gastrointestinal side effects such as nausea and vomiting, raise hypoglycaemia risk (especially with other diabetes medications), and potentially increase the risk of pancreatitis and gallbladder problems. Patients with diabetes, liver disease, or a history of pancreatitis should exercise particular caution.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
Unordered list
Bold text
Emphasis
Superscript
Subscript